Bank of America Issues Positive Forecast for CME Group (NASDAQ:CME) Stock Price

CME Group (NASDAQ:CMEFree Report) had its price objective increased by Bank of America from $200.00 to $219.00 in a research note published on Wednesday,Benzinga reports. Bank of America currently has an underperform rating on the financial services provider’s stock.

CME has been the subject of a number of other research reports. Raymond James raised CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 price target for the company in a research report on Monday, March 10th. Piper Sandler raised their target price on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Royal Bank of Canada boosted their price target on shares of CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a research report on Thursday, February 13th. JPMorgan Chase & Co. lifted their target price on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a research report on Thursday, February 13th. Finally, Keefe, Bruyette & Woods increased their price target on CME Group from $256.00 to $257.00 and gave the company a “market perform” rating in a research report on Friday, February 14th. Four analysts have rated the stock with a sell rating, eight have given a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, CME Group presently has an average rating of “Hold” and a consensus price target of $241.53.

View Our Latest Stock Report on CME

CME Group Trading Up 0.1 %

NASDAQ CME opened at $262.54 on Wednesday. CME Group has a one year low of $190.70 and a one year high of $267.91. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02. The firm has a market cap of $94.61 billion, a P/E ratio of 27.15, a P/E/G ratio of 6.76 and a beta of 0.53. The stock’s 50-day moving average is $251.50 and its 200-day moving average is $236.71.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. Sell-side analysts anticipate that CME Group will post 10.49 earnings per share for the current fiscal year.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Investors of record on Friday, March 7th were given a $1.25 dividend. The ex-dividend date was Friday, March 7th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.90%. This is a boost from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio (DPR) is presently 51.71%.

CME Group announced that its board has authorized a stock buyback program on Thursday, December 5th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

Insiders Place Their Bets

In other CME Group news, Director Howard J. Siegel sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the sale, the director now owns 21,873 shares in the company, valued at $5,686,980. This trade represents a 31.37 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, COO Suzanne Sprague sold 1,500 shares of the business’s stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $256.83, for a total value of $385,245.00. Following the sale, the chief operating officer now owns 8,036 shares in the company, valued at $2,063,885.88. This represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,076 shares of company stock worth $6,871,496 over the last ninety days. Corporate insiders own 0.30% of the company’s stock.

Institutional Trading of CME Group

Hedge funds have recently made changes to their positions in the company. New Age Alpha Advisors LLC grew its holdings in CME Group by 50.0% during the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock worth $30,000 after acquiring an additional 43 shares during the last quarter. Avidian Wealth Enterprises LLC increased its holdings in CME Group by 2.6% in the fourth quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider’s stock valued at $411,000 after purchasing an additional 45 shares during the period. TFC Financial Management Inc. raised its position in CME Group by 8.4% during the 4th quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider’s stock worth $137,000 after purchasing an additional 46 shares during the last quarter. Waldron Private Wealth LLC lifted its holdings in CME Group by 2.0% during the 4th quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider’s stock worth $549,000 after buying an additional 47 shares during the period. Finally, Venturi Wealth Management LLC grew its position in shares of CME Group by 12.1% in the 4th quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider’s stock valued at $101,000 after buying an additional 47 shares during the last quarter. 87.75% of the stock is owned by institutional investors and hedge funds.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.